Cutting early life exposure to parental smoking may lower the risk of developing MS (multiple sclerosis) in those who are genetically predisposed to the disease, research finds

Read Full Article

#MultipleSclerosis #ParentalSmoking #HealthResearch #GeneticRisk #DiseasePrevention

People with multiple sclerosis (MS), having a COVID-19 infection is not associated with worsening MS symptoms or disability, study finds

Read Full Article

#MultipleSclerosis #COVID19 #MSResearch #HealthStudy #ChronicIllness

Eating more fish linked to slower disease progression for multiple sclerosis patients

Read Full Article

#MultipleSclerosis #FishDiet #HealthBenefits #DiseaseProgression #NutritionScience

New cannabis formula promises more effective treatment for epilepsy and multiple sclerosis sufferers. Researchers have increased solubility of cannabidiol by up to 6 times and improved its absorption in the gut, for more consistent and effective results with lower doses of oral CBD medications.

Read Full Article

#CannabisResearch #CBD #EpilepsyTreatment #MultipleSclerosis #HealthInnovation

Researchers identified a new biomarker for predicting the progression of multiple sclerosis. The thickness of an inflammatory cell rim surrounding MS brain lesions was found to directly correlate with the severity and speed of disease progression. 🧠⚡️🔬

Read Full Article

#MultipleSclerosis #BiomarkerResearch #MSProgression #Neuroscience #HealthInnovation

A new blood test allows the identification of individuals at risk for developing multiple sclerosis (MS) 🩸🧠 with a high degree of certainty years before the onset of symptoms.

Read Full Article

#MultipleSclerosis #BloodTest #HealthInnovation #MSAwareness #MedicalBreakthrough

New research suggests that multiple sclerosis may quietly begin affecting the body up to 15 years before the first obvious neurological symptoms appear 🧠🕒✨

Read Full Article

#MultipleSclerosis #NeurologyResearch #ChronicIllness #HealthAwareness #MSAwareness

Most US neurologists prescribing MS drugs have received pharma industry cash 💰 | Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) 🧠 received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, 5 year study finds 📊.

Read Full Article

#MultipleSclerosis #Neurology #HealthcareTransparency #PharmaPayments #MSAwareness

Oral bacterium tied to disability severity in multiple sclerosis (MS) 🦷🧠. Findings connect Fusobacterium nucleatum with MS disease severity. Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders through chronic inflammation.

Read Full Article

#MultipleSclerosis #MSResearch #OralHealth #Fusobacterium #ChronicInflammation

Two new subtypes of MS found in ‘exciting’ breakthrough. Scientists uncovered biological strands using artificial intelligence 🤖🧬 and hope discovery will revolutionise treatment 💉✨.

Read Full Article

#MultipleSclerosis #MSResearch #ArtificialIntelligence #MedicalBreakthrough #HealthInnovation

The immune system’s reaction to the common Epstein-Barr Virus (EBV) can damage the brain 🧠 and contribute to multiple sclerosis (MS) 🦠. A recent study provides new insight into the long-suspected link between EBV and MS - Long-term memory T-cells pick on the wrong protein (ANO2) instead of EBV-antigen.

Read Full Article

#EpsteinBarrVirus #MultipleSclerosis #ImmuneResponse #BrainHealth #MedicalResearch

Researchers 🔬 analysed blood 🩸 from individuals 👥 who had recently been diagnosed with Multiple Sclerosis 🧠 to investigate concentrations of the common environmental contaminants PFAS 🧪 and PCBs 🧪.

Read Full Article

#MultipleSclerosis #MSResearch #PFAS #PCBs #EnvironmentalHealth

🔬 New study shows cerebral-spinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions with 0.94 accuracy.

🔬 The research, involving 160 individuals across three US and Canadian centers, also aimed to stratify MS patients into progressive vs. relapsing forms, achieving a model accuracy of 0.76.

🔬 This advancement in diagnostic testing, published in the Annals of Neurology, utilizes a multiplex proteomic platform and could lead to better personalized treatments for MS.

#Multiplesclerosis #Neurology #MedicalResearch

Yaks may hint at a way to treat brain diseases like "Multiple Sclerosis", a disease that affects your brain and spinal cord.Animals that live at high altitudes, such as yaks have a genetic mutation that may suggest new ways to treat brain diseases like Multiple Sclerosis.

Read Full Article

#BrainHealth #MultipleSclerosis #HighAltitudeBiology

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a new study.

Read Full Article

#EpsteinBarrVirus #Mononucleosis #MultipleSclerosis risk

In people with multiple sclerosis, aerobic training produced the largest reductions in both fatigue severity and fatigue impact among four exercise programs tested in an 8-week randomized trial

Read Full Article

#MultipleSclerosis #AerobicExercise #FatigueManagement

The evolutionary origins of multiple sclerosis : the disappearance of helminths (intestinal worms) from our regions, combined with a genetic susceptibility inherited from our ancestors of the Pontic-Caspian steppe, could explain the increase in cases of multiple sclerosis.

Read Full Article

#MultipleSclerosis #EvolutionaryMedicine #HeritabilityDisease

Uncovering how Epstein-Barr virus drives MS | Harvard T.H. Chan School of Public Health

Read Full Article

#EpsteinBarrVirus #MultipleSclerosis #HarvardPublicHealth

Researchers discover how the Epstein-Barr virus, the most common cause of infectious mono, triggers multiple sclerosis

Read Full Article

#EpsteinBarrVirus #MultipleSclerosis #Neurovirology

🔬 New study from Mass General Brigham reveals how Epstein-Barr virus (EBV) reactivation may trigger multiple sclerosis (MS) attacks. Researchers found distinct immune changes in blood samples up to 3 months before an MS relapse.

🦠 The study, involving 114 MS patients, identified increased EBV activity in immune cells, particularly B cells, which also showed elevated expression of genes linked to MS risk. This offers a timeline of how the reactivated virus interacts with risk genes to cause inflammation.

💡 These findings, published in Nature Medicine, suggest potential for more targeted MS therapies by focusing on EBV or specific immune cells involved in relapses, rather than broad immune suppression.

#MultipleSclerosis #EpsteinBarrVirus #MSResearch